Outsourcing Outlook

Pharmaceutical Technology, Pharmaceutical Technology-01-01-2003, Volume 27, Issue 1

Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.

Related Content:

OutsourcingOutsourcing OutlookPharmaceutical Technology-01-01-2003
How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide
Robust Bioanalytical Studies Can Aid in Regulatory Submissions
Drug Digest: Sterilization’s Horizon: Improving Automation, Single-Use Technologies, and Annex 1